Revolution Medicines, Inc. Common Stock

$157.47
USD
Last updated on --.
24h volume4.32M
24h highest157.98 USD
24h lowest153.18 USD
24h Price movement-0.01%

RVMD recent prices

24 Hours
-0.01%-$0.01
30 days
+12.90%+$17.99
60 days
+59.64%+$58.83
90 days
+54.96%+$55.85

Key data

Previous close157.48 USD
Market cap32.53B USD
Volume4.32M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-6.4500 USD
Net income (FY)-1.37B USD
Revenue (FY)--
Last report dateMay 6, 2026

About Revolution Medicines, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersREDWOOD CITY
Employees (FY)883.00
Net income per employee (FY)-1.55M USD
Listed onNasdaq
Official website

RVMD conversion tables

RVMDRVMD
USDUSD
0.5 RVMD78.73 USD
1 RVMD157.47 USD
5 RVMD787.35 USD
10 RVMD1,574.7 USD
USDUSD
RVMDRVMD
0.5 USD0.0031752 RVMD
1 USD0.0063504 RVMD
5 USD0.031752 RVMD
10 USD0.063504 RVMD

FAQ

RVMD is trading at $157.47, -0.01% over the last 24 hours. Track live moves on the price chart at the top of this page.
The RVMD stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. RVMD is currently trading at $157.47, -0.01% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on RVMD price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. RVMD's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from RVMD; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against RVMD's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Revolution Medicines, Inc. Common Stock's market cap is currently 32.53B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume4.32M
24h highest157.98 USD
24h lowest153.18 USD
24h Price movement-0.01%
RVMDRVMD
USDUSD
Start trade with RVMD Perpetual